世界急诊医学杂志（英文）2024，Vol.15Issue(1)：67-69,3.DOI:10.5847/wjem.j.1920-8642.2024.012
When Glanzmann thrombasthenia encounters antithrombin deficiency:how do we balance the risk and benefit of antithrombotic therapy?
When Glanzmann thrombasthenia encounters antithrombin deficiency:how do we balance the risk and benefit of antithrombotic therapy?
Yu Wang 1Zhihao Liu 2Haoyu Weng 2Jianping Li3
作者信息
- 1. Department of Endocrinology,Peking University First Hospital,Beijing 100034,China
- 2. Department of Cardiology,Peking University First Hospital,Beijing 100034,China
- 3. Department of Cardiology,Peking University First Hospital,Beijing 100034,China||Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education,Health Science Center,Peking University,Beijing 100034,China
- 折叠
引用本文复制引用
Yu Wang,Zhihao Liu,Haoyu Weng,Jianping Li..When Glanzmann thrombasthenia encounters antithrombin deficiency:how do we balance the risk and benefit of antithrombotic therapy?[J].世界急诊医学杂志（英文）,2024,15(1):67-69,3.
